The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)

At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study was to investigate the current worldwide practice. H...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of surgical oncology Ročník 44; číslo 12; s. 1942 - 1948
Hlavní autoři:	Bushati, M., Rovers, K.P., Sommariva, A., Sugarbaker, P.H., Morris, D.L., Yonemura, Y., Quadros, C.A., Somashekhar, S.P., Ceelen, W., Dubé, P., Li, Y., Verwaal, V.J., Glehen, O., Piso, P., Spiliotis, J., Teo, M.C.C., González-Moreno, S., Cashin, P.H., Lehmann, K., Deraco, M., Moran, B., de Hingh, I.H.J.T.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Ltd 01.12.2018
Témata:	Colorectal Neoplasms - pathology Colorectal peritoneal metastases Combined Modality Therapy Cytoreduction Surgical Procedures - methods Cytoreductive surgery Humans Hyperthermia, Induced - methods Hyperthermic intraperitoneal chemotherapy Internet Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Practice Patterns, Physicians' - statistics & numerical data Surveys and Questionnaires Treatment Outcome CRS and HIPEC PSOGI CRC-PM BSA EPIC Cytoreductive surgery PCI IP Hyperthermic intraperitoneal chemotherapy MDT Colorectal peritoneal metastases
ISSN:	0748-7983, 1532-2157, 1532-2157
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study was to investigate the current worldwide practice. HIPEC experts from 19 countries were invited through the Peritoneal Surface Oncology Group International (PSOGI) to complete an online survey concerning their personal expertise and current hospital and countrywide practice. It is estimated that currently more than 3800 patients with CRC-PM (synchronous and metachronous) are annually treated with CRS and HIPEC in 430 centers. Integration of CRS and HIPEC in national guidelines varies, resulting in large treatment disparities between countries. Amongst the experts, there was general agreement on issues related to indication, surgical technique and follow up but less on systemic chemotherapy or proactive strategies. This international survey demonstrates that CRS and HIPEC is now performed on a large scale for CRC-PM patients. Variation in treatment may result in heterogeneity in surgical and oncological outcomes, emphasising the necessity to reach consensus on several issues of this comprehensive procedure. Future initiatives directed at achieving an international consensus statement are needed.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0748-7983 1532-2157 1532-2157
DOI:	10.1016/j.ejso.2018.07.003